Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure

BMJ

Volumn 309, Issue 6958, 1994, Pages 833-

  Hannedouche, T ^a   Landais, P ^a   Goldfarb, B ^a   Esper, n el ^a   Fournier, A ^a   Godin, M ^a   Durand, D ^a   Chanard, J ^a   Mignon, F ^a   Suc, J M ^a   Grunfeld, J P ^a  

^a Department of Nephrology ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; FEMALE; HUMAN; HYPERKALEMIA; HYPERTENSION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACEBUTOLOL; ADOLESCENT; ADULT; AGED; ATENOLOL; BLOOD PRESSURE; BODY WEIGHT; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; PROTEINURIA;

EID: 0028068991     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.309.6958.833     Document Type: Article

References (29)

1. Hostetter TH Olson JL Rennke HG Venkatachalam MA Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-93.
2. Yoshida Y Fogo A Ichikawa I. Glomerular hemodynamic changes v hypertrophy in experimental glomerular sclerosis. Kidney Int 1989; 35: 654-60.
3. Anderson S Rennke HG Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
4. Meyer TW Anderson S Rennke HG Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-9.
5. Yoshida Y Kawamura T Ikoma M Fogo A Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36: 626-35.
6. Parving HH Hommel E Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. BMJ 1988; 297: 1086-91.
7. Bjorck S Mulec H Johnsen SA Norden G Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992; 304: 339-43.
8. Pocock SJ. Clinical trials. A practical approach. Chichester: John Wiley, 1983: 123-41.
9. Maroni BJ Steinman TI Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27: 58-65.
10. Hannedouche T Laude D Dechaux M Grunfeld J-P Elghozi J-L. Plasma 5-hydroxyindoleacetic acid as an endogenous index of renal plasma flow. Kidney Int 1989; 35: 95-8.
11. Dixon WJ Brown MB Engelman L Hill MA Jennrich RI eds. BMDP statistical software manual. Berkeley: University of California Press, 1988.
12. SAS Institute. SAS/STAT user's guide, version 6. Cary, NC:SAS, 1989.
13. Brazy PC Stead WW Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int 1989; 35: 670-4.
14. Alvestrand A Gutierrez A Bucht H Bergstrom J. Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 1988; 3: 624-31.
15. Brazy PC Fitzwilliam JF. Progressive renal disease: role of race and antihypertensive medications. Kidney Int 1990; 37: 1113-9.
16. Hannedouche T Albouze G Chauveau P Lacour B Jungers P. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis 1993; 21 suppl 2: 131-7.
17. Mann JFE Reisch C Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. Nephron 1990; 55(suppl 1): 38-42.
18. Ruilope LM Miranda B Morales JM Rodicio JL Romero JC Raij L. Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 1989; 13: 120-6.
19. Kamper A Strongaard S Leyssac PP. Effects of enalapril on the progression of chronic renal failure. Am J Hypertens 1992; 5: 423-30.
20. Cameron JS. Proteinuria and progression in human glomerular disease. Am J Nephrol 1990; 10 suppl 1: 81-7.
21. Rosenberg ME Chmielewski D Hostetter TH. Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest 1990; 85: 1144-9.
22. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987; 32: 78-83.
23. Moorehead JF Chan MK El Nahas M Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; ii: 1309-11.
24. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36: 272-9.
25. Norman JT. The role of angiotensin II in renal growth. Renal Physiol Biochem 1991; 14: 175-85.
26. Fenoy FJ Scicli G Carretero O Roman R. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension 1991; 17: 1038-44.
27. Modification of Diet in Renal Disease Study Group. Design and statistical issues of the modification of diet in renal disease trial. Control Clin Trial 1991; 12: 566-86.
28. Levey AS Perrone RD Madias NE. Serum creatinine and renal function. Annu Rev Med 1988; 39: 465-90.
29. Davies D Shock NW. The variability of measurement of inulin and diodrast tests of kidney function. J Clin Invest 1950; 29: 491-5.